Increased EPHA4 signaling but decreased EPHB2 signaling have been reported to exacerbate Alzheimer’s disease pathology in mouse models (76, 77, 78, 79, 80, 81). This evidence concerns the gene EPHB2 and early-onset autosomal dominant Alzheimer disease.